Delanterone (INN ) (developmental code name GBR-21162), also known as 1α-methylandrosta-4,16-dien-3-one, is a steroidal antiandrogen described as an anti-acne agent which was never marketed.[1][2][3] The compound showed poor efficacy as an antiandrogen in vivo in animals, suggestive of low activity or a short terminal half-life, and likely in relation to this was not further developed.[3] It was described and characterized in the literature in 1977.[1][3]
Clinical data | |
---|---|
Other names | GBR-21162; 1α-Methylandrosta-4,16-dien-3-one |
Identifiers | |
| |
CAS Number |
|
PubChem CID |
|
ChemSpider |
|
UNII |
|
ChEMBL |
|
Chemical and physical data | |
Formula | C20H28O |
Molar mass | 284.443 g·mol−1 |
3D model (JSmol) |
|
| |
|